Biosimilars Forum

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

September 16, 2016 Biosimilars Forum

Biosimilars Forum Applauds Outcome of BsUFA Negotiations; Pleased to Have Played Important Role in Decision-Making

June 3, 2016 Biosimilars Forum

Biosimilars Forum Submits Comments in Response to FDA Draft Industry Guidance on Labeling for Biosimilar Products

March 31, 2016 Biosimilars Forum

Biosimilars Forum Issues Statement on FDA Draft Industry Guidance on Labeling for Biosimilar Products

March 16, 2016 Biosimilars Forum

Biosimilars Forum Issues Statement on Proposed Part B Drug Payment Model

February 9, 2016 Biosimilars Forum

Biosimilars Forum Statement: FDA Arthritis Advisory Committee Meeting for Biosimilar to Remicade (Infliximab), Submitted by Celltrion, Inc.

February 4, 2016 Biosimilars Forum

Biosimilars Forum Issues Statement Regarding House Energy & Commerce, Subcommittee on Health Biosimilars Hearing, Launch of New Biosimilars Education Initiative

February 1, 2016 Biosimilars Forum

Biosimilars Forum Launches “Partnership for Biosimilars Education and Access”

November 5, 2015 Biosimilars Forum

EPIRUS Biopharmaceuticals Joins Biosimilars Forum to Help Educate Patients and Health Care Providers on Importance of Biosimilars

October 30, 2015 Biosimilars Forum

Biosimilars Forum Disappointed with CMS Final Rule on Biosimilar Payment and Coding

October 27, 2015 Biosimilars Forum

Biosimilars Forum Comments on FDA Naming Guidance